國立高雄大學圖資館 |

Neuroproteomics as a tool for understanding schizophrenia

Record Type:	Electronic resources : Monograph/item
Title/Author:	Neuroproteomics as a tool for understanding schizophreniaedited by Daniel Martins-de-Souza.
other author:	Martins-de-Souza, Daniel.
Published:	Cham :Springer International Publishing :2022.
Description:	viii, 143 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	SchizophreniaMolecular aspects.
Online resource:	https://doi.org/10.1007/978-3-030-97182-3
ISBN:	9783030971823$q(electronic bk.)

Neuroproteomics as a tool for understanding schizophrenia
Neuroproteomics as a tool for understanding schizophrenia[electronic resource] /edited by Daniel Martins-de-Souza. - Cham :Springer International Publishing :2022. - viii, 143 p. :ill. (some col.), digital ;24 cm. - Proteomics, metabolomics, interactomics and systems biology,v. 14002730-6224 ;. - Proteomics, metabolomics, interactomics and systems biology ;1118..

1. Postmortem brains: what can proteomics tell us about the sources of schizophrenia? -- 2. What can we learn from animal models to study schizophrenia? -- 3. Modeling schizophrenia in vitro: challenges and insights on studying brain cell -- 4. Schizophrenia outside the brain -- 5. Molecular features triggered by antipsychotic medication in brain cells -- 6. Known and Unexplored Post-Translational Modification Pathways in Schizophrenia -- 7. Molecular findings guiding the modulation of the endocannabinoid system as a potential target to treat schizophrenia -- 8. Metabolomics: A powerful tool to understand the schizophrenia biology -- 9. Modulating specific pathways in vitro to understand the synaptic dysfunction of schizophrenia -- 10. Proteomics and schizophrenia: the evolution of a great partnership.

Over the past decade, neuroproteomics has shed light on the molecular features of schizophrenia by depicting biological processes involved with its establishment, maintenance and treatment. These studies have also pointed to potential biomarkers applicable to diagnosis and medication monitoring. Edited by a leader in the field of neuroproteomics with contributions from subject experts, this new volume will address recent findings and compile evidence from difference perspectives-such as human samples, animal models, pluripotent stem cell-derived in vitro pre-clinical models-and provide findings to inform the development of innovative future treatment strategies. This volume will be useful for a broad audience of researchers and professionals, including biologists, neurologists, psychiatrists, analytical chemists, and pharmacists, among others. Provides comprehensive overview on how neuroproteomics helped depicting the molecular features of schizophrenia Addresses biological processes, treatment strategies, and recent research findings associated to schizophrenia Addresses current research challenges, future strategies, and clinical applications.

ISBN: 9783030971823$q(electronic bk.)

Standard No.: 10.1007/978-3-030-97182-3doiSubjects--Topical Terms:

933142
Schizophrenia
--Molecular aspects.

LC Class. No.: RC514 / .N48 2022

Dewey Class. No.: 616.898

Neuroproteomics as a tool for understanding schizophrenia
LDR:03060nmm a2200325 a 4500 001 628747
003 DE-He213
005 20220805131058.0
007 cr nn 008maaau
008 230224s2022 sz s 0 eng d
020 $a 9783030971823$q(electronic bk.)
020 $a 9783030971816$q(paper)
024 7 $a 10.1007/978-3-030-97182-3 $2 doi
035 $a 978-3-030-97182-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC514 $b .N48 2022
072 7 $a PSAK $2 bicssc
072 7 $a SCI029000 $2 bisacsh
072 7 $a PSAK $2 thema
082 0 4 $a 616.898 $2 23
090 $a RC514 $b .N494 2022
245 0 0 $a Neuroproteomics as a tool for understanding schizophrenia $h [electronic resource] / $c edited by Daniel Martins-de-Souza.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a viii, 143 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Proteomics, metabolomics, interactomics and systems biology, $x 2730-6224 ; $v v. 1400
505 0 $a 1. Postmortem brains: what can proteomics tell us about the sources of schizophrenia? -- 2. What can we learn from animal models to study schizophrenia? -- 3. Modeling schizophrenia in vitro: challenges and insights on studying brain cell -- 4. Schizophrenia outside the brain -- 5. Molecular features triggered by antipsychotic medication in brain cells -- 6. Known and Unexplored Post-Translational Modification Pathways in Schizophrenia -- 7. Molecular findings guiding the modulation of the endocannabinoid system as a potential target to treat schizophrenia -- 8. Metabolomics: A powerful tool to understand the schizophrenia biology -- 9. Modulating specific pathways in vitro to understand the synaptic dysfunction of schizophrenia -- 10. Proteomics and schizophrenia: the evolution of a great partnership.
520 $a Over the past decade, neuroproteomics has shed light on the molecular features of schizophrenia by depicting biological processes involved with its establishment, maintenance and treatment. These studies have also pointed to potential biomarkers applicable to diagnosis and medication monitoring. Edited by a leader in the field of neuroproteomics with contributions from subject experts, this new volume will address recent findings and compile evidence from difference perspectives-such as human samples, animal models, pluripotent stem cell-derived in vitro pre-clinical models-and provide findings to inform the development of innovative future treatment strategies. This volume will be useful for a broad audience of researchers and professionals, including biologists, neurologists, psychiatrists, analytical chemists, and pharmacists, among others. Provides comprehensive overview on how neuroproteomics helped depicting the molecular features of schizophrenia Addresses biological processes, treatment strategies, and recent research findings associated to schizophrenia Addresses current research challenges, future strategies, and clinical applications.
650 0 $a Schizophrenia $x Molecular aspects. $3 933142
650 0 $a Schizophrenia $x Physiological aspects. $3 933143
650 0 $a Proteomics. $3 220403
650 1 4 $a Genomics. $3 209057
650 2 4 $a Computational and Systems Biology. $3 911810
650 2 4 $a Neuroscience. $3 297547
700 1 $a Martins-de-Souza, Daniel. $3 725424
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Proteomics, metabolomics, interactomics and systems biology ; $v 1118. $3 834894
856 4 0 $u https://doi.org/10.1007/978-3-030-97182-3
950 $a Biomedical and Life Sciences (SpringerNature-11642)